Check Point Slides After Tepid Q2 Growth and Ongoing Hardware Weakness

Check Point Software Technologies (CHKP) is down 9.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The selloff appears tied to a mixed second-quarter report that showed only modest top-line growth, continued weakness in firewall appliance demand, and no raise to full-year guidance. Even though earnings per share came in above the company’s guided range, investors may have focused on the slow revenue growth and signs that part of the profit support came from a one-time research and development incentive.

Details:

Second-quarter revenue was $674 million, up just 1% from a year earlier, while subscription revenue rose 12% to $333 million.

The company highlighted lower demand for firewall appliances, suggesting legacy hardware pressure is still offsetting stronger subscription and emerging-technology trends.

Non-GAAP operating income slipped to $260 million from $271 million a year earlier, even as the quarter included about $28 million of benefit tied to Israel’s new research and development incentive program.

Full-year 2026 guidance was maintained rather than raised, which may have disappointed investors looking for clearer evidence of a faster rebound in the second half.

Sources:

Check Point Software, Check Point Software Investor Presentation, Globes

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CHKP Insider Trading Activity

$CHKP insiders have traded $CHKP stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $CHKP stock by insiders over the last 6 months:

YOAV CHELOUCHE sold 25,000 shares for an estimated $3,506,940
SHENHAV TAL SHAVIT sold 25,000 shares for an estimated $3,076,747
JERRY T UNGERMAN sold 25,000 shares for an estimated $3,063,632

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive CHKP Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$CHKP Hedge Fund Activity

We have seen 272 institutional investors add shares of $CHKP stock to their portfolio, and 385 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CLEARBRIDGE INVESTMENTS, LLC removed 987,465 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $141,059,375
SCHRODER INVESTMENT MANAGEMENT GROUP removed 878,756 shares (-97.3%) from their portfolio in Q1 2026, for an estimated $125,530,294
PICTET ASSET MANAGEMENT HOLDING SA removed 703,542 shares (-92.2%) from their portfolio in Q2 2026, for an estimated $92,466,525
ARIEL INVESTMENTS, LLC removed 464,185 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $66,308,827
BANK OF NEW YORK MELLON CORP removed 456,790 shares (-69.8%) from their portfolio in Q1 2026, for an estimated $65,252,451
FREESTONE GROVE PARTNERS LP added 388,273 shares (+inf%) to their portfolio in Q1 2026, for an estimated $55,464,798
GOLDMAN SACHS GROUP INC added 360,741 shares (+56.4%) to their portfolio in Q1 2026, for an estimated $51,531,851

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CHKP Congressional Stock Trading

Members of Congress have traded $CHKP stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CHKP stock by members of Congress over the last 6 months:

REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 06/01.
SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$CHKP Analyst Ratings

Wall Street analysts have issued reports on $CHKP in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

Susquehanna issued a "Positive" rating on 05/01/2026
BWG Global issued a "Negative" rating on 04/14/2026

To track analyst ratings and price targets for $CHKP, check out Quiver Quantitative's $CHKP forecast page.

$CHKP Price Targets

Multiple analysts have issued price targets for $CHKP recently. We have seen 18 analysts offer price targets for $CHKP in the last 6 months, with a median target of $150.0.

Here are some recent targets:

Patrick Colville from Scotiabank set a target price of $185.0 on 07/06/2026
John Difucci from Guggenheim set a target price of $188.0 on 07/01/2026
Keith Bachman from BMO Capital set a target price of $135.0 on 05/04/2026
Fatima Boolani from Citigroup set a target price of $125.0 on 05/04/2026
Shyam Patil from Susquehanna set a target price of $140.0 on 05/01/2026
Peter Levine from Evercore ISI Group set a target price of $130.0 on 05/01/2026
Dan Ives from Wedbush set a target price of $160.0 on 05/01/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.